Agreement Reached on Primary Endpoint and Phase 3 Trial Design. Oral APX3330 is a Late-Stage Clinical Asset Available for Partnering. FARMINGTON HILLS, Mich., Dec. 19, 2024 (GLOBE ...
The $20.00 per share represents 254% premium to the last closing share price for Singular’s common stock prior to the September 12, 2024 public disclosure of Deerfield’s initial acquisition proposal.
6d
CNW/ - WildBrain Ltd. ("WildBrain" or the "Company") (TSX: WILD), a global leader in kids' and family entertainment, has ...
Fresh Vine Wine Inc. Exclusive Conversation with Aaron Day, CEO of Amaze Software, Available in Link Below. CHARLOTTE, NC / ...
As climate disasters multiply, what did we learn this year, and what is the way ahead? We certainly don’t want an ...
The Company commenced proceedings on May 26, 2022, to seek declarations and orders for specific performance relating to certain provisions of the amended 2004 Equity Participation and Earn-in ...
Riyadh, KSA: The ORGATEC WORKSPACE Saudi Arabia will make its debut in Riyadh in September 2025. This is the result of a ...
In parallel with these efforts, the Company is preparing to commence going out of business (“GOB”) sales at all remaining Big ...
Rising China–US tensions risk destabilising the Taiwan Strait, challenging the UK’s longstanding position and exposing its ...
FlexShopper has extended the expiration of the rights offering to 5:00 pm ET on Friday, January 10, 2025 (the “Extended Expiration Time”). Only shareholders that exercise their initial units will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback